InsidersTradesSigma
XSpray Pharma AB (publ): insider trades · Finland · FIN-FSA
FI:xspray-pharma-ab-publSE0026140865FI·FIN-FSA
Discover the full management transaction log of XSpray Pharma AB (publ), a listed issuer based in Finland. Shares are listed on FI FI, under the oversight of FIN-FSA. The latest transaction was disclosed on 22 April 2026 (Purchase). Among the most active insiders: Anders Lennart Bladh, Ribbskottet. The full history is accessible without an account.
10
Insider Decl.
0
Thresholds
€6m
10 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
26.00 €
Analyst consensus
Valuation
P/Book1.9x
Beta-0.06
Balance sheet & cash
Debt / Equity26%
Profitability & ownership
ROE-28.6%
ROA-12.7%
% insiders28.3%
% institutions41.9%
Last declaration on 22 April 2026
Declarations10 total
Executives●Purchase13FIN-FSA
€881,638475,764 shares@ €1.853137.8% of flow
BTA (betald tecknad aktie)
FI:A003X725-1·
Ideal exit: 16 Jan 2027 (T+270)
Executives●Purchase9FIN-FSA
€3,3691,818 shares@ €1.85310.1% of flow
BTA (betald tecknad aktie)
FI:A003X724-1·
Ideal exit: 16 Jan 2027 (T+270)
Executives●Purchase13FIN-FSA
€56,37130,420 shares@ €1.853139.2% of flow
BTA (betald tecknad aktie)
FI:A003X722-1·
Ideal exit: 16 Jan 2027 (T+270)
Executives●Purchase13FIN-FSA
€1m733,618 shares@ €1.853139.0% of flow
BTA (betald tecknad aktie)
FI:A003X719-1·
Ideal exit: 16 Jan 2027 (T+270)
Executives●Purchase9FIN-FSA
€76,29323,821 shares@ €3.20283.3% of flow
BTA (betald tecknad aktie)
FI:A003S242-2·
Ideal exit: 9 Jun 2026 (T+270)
Executives●Purchase15FIN-FSA
€87,48527,467 shares@ €3.185160.8% of flow
BTA (betald tecknad aktie)
FI:A003S244-1·
Ideal exit: 6 Jun 2026 (T+270)
Executives●Purchase17FIN-FSA
€5,2621,652 shares@ €3.1851100.0% of flow
BTA (betald tecknad aktie)
FI:A003S243-1·
Ideal exit: 6 Jun 2026 (T+270)
Executives●Purchase15FIN-FSA
€1m430,000 shares@ €3.185158.8% of flow
BTA (betald tecknad aktie)
FI:A003S241-1·
Ideal exit: 6 Jun 2026 (T+270)
Executives●Purchase15FIN-FSA
€592186 shares@ €3.1851100.0% of flow
BTA (betald tecknad aktie)
FI:A003S257-1·
Ideal exit: 6 Jun 2026 (T+270)
Executives●Purchase15FIN-FSA
€2m666,926 shares@ €3.185161.0% of flow
BTA (betald tecknad aktie)
FI:A003S147-1·
Ideal exit: 6 Jun 2026 (T+270)
10 of 10 declarations